Shire plc (SHPGY) Q3 2011 Earnings Call October 28, 2011 9:00 am ET Executives Michael Cola - President of Specialty Pharmaceuticals, Member of Senior Staff Committee and Member of Management Committee Graham Hetherington - Chief Financial Officer, Principal Accounting Officer and Director Sylvie Gregoire - President of Human Genetic Therapies Business and Member of Management Committee Angus Russell - Chief Executive Officer and Executive Director Jeff Jonas - Senior Vice President of Research & Development for Pharmaceuticals Business Eric Rojas - Director of Investor Relations - North America Analysts Ken Cacciatore - Cowen and Company, LLC, Research Division Thomas J. Russo - Robert W. Baird & Co. Incorporated, Research Division Gary Nachman - Susquehanna Financial Group, LLLP, Research Division David M. Steinberg - Deutsche Bank AG, Research Division Keyur Parekh - Goldman Sachs Group Inc., Research Division Luisa Hector - Crédit Suisse AG, Research Division Peter Verdult - Morgan Stanley, Research Division Graham Parry - BofA Merrill Lynch, Research Division Frank H. Pinkerton - SunTrust Robinson Humphrey, Inc., Research Division Guillaume van Renterghem - UBS Investment Bank, Research Division PresentationOperator
Good day, ladies and gentlemen, and welcome to the Shire's 2011 Third Quarter Results hosted by Eric Rojas. My name is Joan, and I'm your event manager. [Operator Instructions] I would like to advise all parties that this call is being recorded for replay purposes, and now, I'd like to hand it over to Eric. Go ahead please. Eric Rojas Good morning, and good afternoon, everyone. Thank you for joining us today for Shire's Third Quarter 2011 Financial Results.